Status:
NOT_YET_RECRUITING
Assessing the Feasibility of the Patient-Reported Outcomes Based Model for Community Care of Patients With Axial Spondyloarthritis Via a Type 1 Pilot Hybrid Effectiveness-Implementation Trial Using the RE-AIM Framework
Lead Sponsor:
Singapore General Hospital
Conditions:
Axial Spondyloarthritis
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to facilitate the implementation of PROMs-based care for patients with axial spondyloarthritis. The main questions it aims to answer are: * What are the barriers, ...
Eligibility Criteria
Inclusion
- diagnosed with axial spondyloarthritis according to the 2009 ASAS Classification Criteria of AxSpA
- has been receiving care in Singapore General Hospital for at least 6 months
- aged 21 years and above
Exclusion
- Bath Ankylosing Spondylitis Disease Activity Index score of \>4
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06968247
Start Date
June 1 2025
End Date
May 1 2027
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, Singapore, 169608